Job details
- Job Type:Contract
- Salary:$60 - $80 per hour + depending on experience
- Location:Connecticut
- Reference:RE-12489887
Contact us
- Contact Telephone:+1 212 707 8499
The main responsibilities of this role include, but are not limited to:
* Processes clinical data for analysis of clinical trials for Phase 1-4 in the Infectious Disease Therapeutic Area
* Programs study report tables, listings and figures as well as ad-hoc requests for publications, posters and other needs
* Provides programming and general support for Advisory Committee meetings
* Develops SAS coding and table templates for preparing, processing and analyzing clinical data
* Follows good programming practices; adequately documents programs while being compliant with ICH-GCG guidelines and company SOPs
* Generates and QC summary tables, data listings and graphs for in-house analyses of study data or publications using SAS standard coding practices
* Develops tools to improve programming efficiency or quality
* Creates and reviews programming plans and specifications for datasets and TLFs
TRAINING AND EDUCATION:
* A minimum of a Bachelor's degree in Computer Science, Mathematics, Statistics, Pharmaceuticals Sciences, Life Sciences and related areas is required; Master's degree is preferred
* SAS certification is a plus
PRIOR EXPERIENCE:
* A minimum of 5 years hands on career experience with SAS in the pharmaceutical or biotechnology industry
* Experience as a lead programmer for a study is preferred
* Strong understanding of clinical trial data and extremely hands on in data manipulations, analysis and reporting
* Well versed with CDISC conventions, i.e., SDTM and ADaM models
* Very familiar with SAS Statistical Procedures
* Knowledge of applicable standards, regulations and ICH-GCP for clinical study conduct
* Excellent knowledge of SAS programming and associated features and their applications in pharmaceuticals industry environment in particular clinical trial data setting
To find out more about Real please visit www.realstaffing.com
0 comments:
Post a Comment